LMS announces second quarter 2008 revenues
November 01 2007 - 8:00AM
PR Newswire (US)
Ytd revenues increase 87% to $1.7 million Quarterly revenues
increase 166% to $734,000 MONTREAL, Nov. 1 /PRNewswire-FirstCall/
-- LMS Medical Systems (TSX: LMZ, AMEX: LMZ), a healthcare
technology company and developer of the CALM(R) clinical
information system and risk management software tools for
obstetrics, today reported revenues for the second quarter of
fiscal 2008 ended September 30, 2007. All amounts are in Canadian
dollars. Revenues in Q2 2008 increased by 166% to $735,000 from
$276,000 in Q2 2007. Our recurring maintenance and technical
revenues continue to grow from our installed client base and
increased by 36% to $703,000 from $517,000 for the comparative
six-month period. Year-to-date revenues increased by 87% to $1.7
million from $907,000. In conjunction with seasonally stronger
winter and spring quarters (Q3 and Q4) and corporate streamlining
of operations, management anticipates reaching a cash flow break
even at the end of the current fiscal year. Complete results for
the second quarter along with Management's Discussion and Analysis
will be released in normal course on or about November 14th and
will be available in Canada at http://www.sedar.com/, in the United
States at http://www.sec.gov/ and at http://www.lmsmedical.com/.
ABOUT LMS LMS is a leader in the application of advanced
mathematical modeling and neural networks for medical use. The LMS
CALM(TM) Suite provides physicians, nursing staff, risk managers
and hospital administrators with clinical information systems and
risk management tools designed to improve outcomes and patient care
for mothers and their infants during childbirth. Except for
historical information contained herein, the matters discussed in
this news release are forward-looking statements. Because these
forward-looking statements involve risks and uncertainties, there
are important factors that could cause actual results to differ
materially from those expressed implied by the forward-looking
statements including, but without limitation, economic conditions
in general and in the healthcare market, the demand for and market
for our products in domestic and international markets, our current
dependence on the CALM product suite, the challenges associated
with developing new products and obtaining regulatory approvals if
necessary, research and development activities, the uncertainty of
acceptance of our products by the medical community, the lengthy
sales cycle for our products, third party reimbursement,
competition in our markets, including the potential introduction of
competitive products by others, our dependence on our distributors,
physician training, enforceability and the costs of enforcement of
our patents, potential infringements of our patents and the other
factors set forth from time to time in the Company's filings with
the United States Securities and Exchange Commission and with the
Canadian Securities Commissions. The Company has no intention of or
obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise.
DATASOURCE: LMS MEDICAL SYSTEMS INC. CONTACT: Yves Grou, Chief
Financial Officer, LMS Medical Systems Inc., (514) 488-3461 Ext.
238, Fax: (514) 488-1880, , http://www.lmsmedical.com/
Copyright